Please assess the completion status of the following clinical trial:

Trial Title: Parafricta Bootees vs UK Standard Care to Prevent Heel Pressure Ulcers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~The eligibility criteria for this study at the time of recruitment were:~* Adult of age 18 years or over~* Admitted to secondary care in an in-patient hospital (with no specified interval from admission to hospital to study recruitment)~* Bedbound or unable to walk independently and requiring assistance to transfer to a chair~* 'Very high' risk group for pressure ulceration (defined by a Waterlow Score of 20 or more)~* No existing heel pressure ulcers of EPUAP/NPUAP/PPPIA Category 1 or above or any other type of wound on the feet.~* Patient was not being treated with pressure offloading boots.~* Patient was not being treated with a heel cast.~Exclusion Criteria:~• Patients with a single or double lower limb amputation were not eligible to participate in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard care alone (Type: NO_INTERVENTION): Patients randomly allocated to standard care will be cared for on the appropriate mattress indicated for use in that participating centre according to local policy e.g. foam mattress or dynamic air mattress. Standard care may also include a mattress overlay or the use of a wedge or pillows to maintain the position of the participant, or pressure offloading boots on the foot if the need arises during the study period.
- Parafricta bootees plus standard care (Type: EXPERIMENTAL): Patients randomly allocated to Parafricta plus standard care will be cared for on the appropriate mattress as above and care may possibly include a mattress overlay or the use of a wedge or pillows. Participants will in addition be issued with Parafricta bootees (one pair and up to two spare pairs). The patient and clinical staff and the patient's carers will be instructed in the use of Parafricta bootees, which are intended to be worn throughout the day and night and removed only for normal daily washing or examination of the patient's feet. Either the slip-on bootees or the Velco-closure bootees will be selected for the participant at the judgment of the clinical ward nurses.

Based on this trial design, predict the completion outcome and termination type (if applicable).